z-logo
open-access-imgOpen Access
Health Factors Associated with Frailty Biomarkers in the Elderly
Author(s) -
Jair Sindra Virtuoso,
Kelly Cristina Paiva Rosa,
Renato Ribeiro Mendonça,
Sheilla Tribess
Publication year - 2021
Publication title -
journal of medical and health studies
Language(s) - English
Resource type - Journals
ISSN - 2710-1452
DOI - 10.32996/jmhs.2021.2.2.1
Subject(s) - medicine , quartile , gerontology , cross sectional study , anthropometry , poisson regression , epidemiology , activities of daily living , physical therapy , environmental health , population , confidence interval , pathology
Background: Few studies associate adverse health factors with frailty defined by biomarkers. Aim: To evaluate the association of adverse health factors in elderly people (controlled by age group, gender, and activity) with the combined analysis of leukocytes and brain-derived neurotrophic factor (BDNF). Method: The study was a cross-sectional epidemiological investigation of an integral part of the ELSIU (Uberaba Elderly Health Study), consisting of a sample of 241 elderly people. The data collection involved physical performance tests, anthropometric measurements, and a questionnaire through individual interviews. Fragility was defined by the concomitant presence of BDNF serum levels ≤1888.42 mg/dL (first quartile) and a leukocyte count lower than 4, 000 mm³ or higher than 9,290 mm³. For the data analysis, descriptive statistic procedures (frequency, mean) and Poisson regression were used, p ≤ 0.05. Results: The prevalence of frailty was 8.7%, and this condition was more prevalent in elderly individuals who were hospitalized in the last three months (RP = 7.33) and among those with disability in the basic activities of daily living (BADLs) (RP = 7.64), controlled by age group, gender and the level of physical activity. Conclusion: The early identification of frailty using biomarkers associated with health factors (hospitalization and disability in BADLs) may provide early intervention for these individuals.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here